Elizabeth Ann Winzeler, Ph.D.
Affiliations: | 1999-2012 | Cell Biology | Genomics Institute of the Novartis Research Foundation |
| 2000-2012 | Cell Biology | Scripps Research Institute, La Jolla, La Jolla, CA, United States | |
| 2012- | Pediatrics | University of California, San Diego, La Jolla, CA |
Area:
microbiology, chemistry, genetics, genomics, bioinformaticsWebsite:
https://winzeler.ucsd.edu/Google:
"Elizabeth Winzeler"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Lucy Shapiro | grad student | 1990-1996 | Stanford University Medical School |
| Ronald W. Davis | post-doc | 1996-1999 | Stanford University Medical School |
Children
Sign in to add trainee| Jason Young | grad student | Scripps Institute | |
| Matthew Abraham | grad student | 2014- | UCSD |
| Madeline Luth | grad student | 2016- | UCSD |
| Neekesh Dharia | grad student | 2009 | Scripps Institute |
| Victoria Corey | grad student | 2012-2016 | UCSD |
| Jaeson Calla | post-doc | 2017- | UCSD |
| Karine G. Le Roch | post-doc | 2000-2005 | Scripps Institute |
| Selina Bopp | post-doc | 2007-2012 | Scripps Institute |
| Case W. McNamara | post-doc | 2007-2012 | Genomics Institute of the Novartis Research Foundation |
| Annie Cowell | post-doc | 2015-2018 | UCSD |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Collins JE, Lee JW, Rocamora F, et al. (2023) Antiplasmodial peptaibols act through membrane directed mechanisms. Cell Chemical Biology |
| Coonahan E, Gage H, Chen D, et al. (2023) Whole-genome surveillance identifies markers of drug resistance and novel genomic regions under selection in Mozambique. Mbio. e0176823 |
| Mandt REK, Luth MR, Tye MA, et al. (2023) Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance. Elife. 12 |
| Siqueira-Neto JL, Wicht KJ, Chibale K, et al. (2023) Antimalarial drug discovery: progress and approaches. Nature Reviews. Drug Discovery |
| Tilley L, Xie S, Wang Y, et al. (2023) Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase. Research Square |
| Kümpornsin K, Kochakarn T, Yeo T, et al. (2023) Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum. Nature Communications. 14: 3059 |
| Mittal N, Davis C, McLean P, et al. (2023) Human nuclear hormone receptor activity contributes to malaria parasite liver stage development. Cell Chemical Biology. 30: 486-498.e7 |
| Xie S, Griffin MDW, Winzeler EA, et al. (2023) Targeting Aminoacyl tRNA Synthetases for Antimalarial Drug Development. Annual Review of Microbiology |
| Bopp S, Pasaje CFA, Summers RL, et al. (2023) Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation. Nature Communications. 14: 1455 |
| Bohmer MJ, Wang J, Istvan ES, et al. (2023) Human Polo-like Kinase Inhibitors as Antiplasmodials. Acs Infectious Diseases |